Table 5 Vax sequence model - OR of non response from fitting a logistic regression analysis
From: Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
Logistic regression of the risk of no response to additional dose | |||||
Unadjusted | Adjusted* | ||||
Odds ratio (95% CI) | p-value | Odds ratio (95% CI) | p-value | &Type III p-value | |
Vaccine sequence | |||||
nAbs titres | |||||
2BNT162b2 + mRNA-1273 | 1 | 1 | 0.326 | ||
mRNA-1273 | 0.46 (0.07, 2.82) | 0.398 | 0.45 (0.07, 2.82) | 0.391 | |
2mRNA-1273 + BNT162b2 | |||||
BNT162b2 | 1.32 (0.25, 6.86) | 0.744 | 1.01 (0.18, 5.58) | 0.994 | |
IFN-γ | |||||
2BNT162b2 + mRNA-1273 | 1 | 1 | 0.074 | ||
mRNA-1273 | 0.41 (0.09, 1.77) | 0.230 | 0.39 (0.09, 1.74) | 0.218 | |
2mRNA-1273 + BNT162b2 | 0.36 (0.04, 3.21) | 0.358 | 0.33 (0.04, 3.01) | 0.325 | |
BNT162b2 | 2.42 (0.73, 8.05) | 0.148 | 1.96 (0.57, 6.81) | 0.288 | |
